Your browser doesn't support javascript.
loading
ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression.
Zhang, Huanling; Li, Yanyan; Liu, Xiaoping; Liang, Zhaoduan; Yan, Mengyong; Liu, Qiang; Chen, Anan; Bao, Yifeng; Zhou, Chengzhi; Li, Shiyue; Yee, Cassian; Li, Yi.
Afiliación
  • Zhang H; School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.
  • Li Y; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Liu X; School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.
  • Liang Z; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Yan M; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Liu Q; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Chen A; XiangXue Life Sciences Research Centre, XiangXue Pharmaceutical Co. Ltd, Guangzhou, Guangdong, China.
  • Bao Y; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Zhou C; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Li S; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.
  • Yee C; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institutes of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Li Y; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institutes of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Immunology ; 155(2): 238-250, 2018 10.
Article en En | MEDLINE | ID: mdl-29791021
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Activación de Linfocitos / Terapia de Inmunosupresión / Linfocitos T Reguladores / Citotoxicidad Inmunológica / Receptor de Muerte Celular Programada 1 / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Immunology Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Activación de Linfocitos / Terapia de Inmunosupresión / Linfocitos T Reguladores / Citotoxicidad Inmunológica / Receptor de Muerte Celular Programada 1 / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Immunology Año: 2018 Tipo del documento: Article País de afiliación: China